
- /
- Supported exchanges
- / BE
- / OLY1.BE
OLYMPUS (OLY1 BE) stock market data APIs
OLYMPUS Financial Data Overview
There is no Profile data available for OLY1.BE.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get OLYMPUS data using free add-ons & libraries
Get OLYMPUS Fundamental Data
OLYMPUS Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
OLYMPUS News

How the U.S. Launch of VISERA S Strengthens Olympus' Medtech Story (TSE:7733)
Earlier this month, Olympus Corporation announced the U.S. launch of its VISERA S OTV-S500 imaging platform, featuring advanced diagnostic and visualization technologies for ENT and urology applicatio...


Olympus Announces Distribution Partnership with MacroLux Medical for Single-Use Urology Products
WESTBOROUGH, Mass., Sept. 4, 2025 /CNW/ -- Olympus Corp., a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced today an exclusive glo...

Olympus Announces U.S. Launch of Newest Imaging Platform for ENT and Urological Applications
VISERA™ S Offers Advanced Diagnostic Imaging Capabilities in a Variety of Patient Settings CENTER VALLEY, Pa., Sept. 2, 2025 /PRNewswire/ -- Olympus Corporation, a global medical technology company...

Smart Pills Company Evaluation Report 2025 | Medtronic, Olympus, and CapsoVision Lead with Minimally Invasive and AI-Enhanced Medical Technologies
Company Logo The 360 Quadrants analysis highlights the leaders in the global Smart Pills market, evaluating over 102 companies. Smart pills, also known as ingestible sensors or digital pills, offer r...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.